|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investment properties | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Building and other improvements | ||||||||||||||||||||
| Construction in progress | ||||||||||||||||||||
| Total | ||||||||||||||||||||
| Less accumulated depreciation | ||||||||||||||||||||
| Net investment properties | ||||||||||||||||||||
| Cash, cash equivalents, and restricted cash | ||||||||||||||||||||
| Investment in unconsolidated entities | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Accounts and rents receivable | ||||||||||||||||||||
| Deferred costs and other assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Debt, net | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Distributions payable | ||||||||||||||||||||
| Intangible liabilities, net | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Preferred stock, $0.001 par value, 40,000,000 shares authorized, none outstanding | ||||||||||||||||||||
| Common stock, $0.001 par value, 146,000,000 shares authorized, 77,978,431 shares issued and outstanding as of September 30, 2026 and 77,691,533 shares issued and outstanding as of December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Distributions in excess of accumulated net income | ||||||||||||||||||||
| Accumulated comprehensive income | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity |
Loading...
